
Antioxidants in 2020: Their next phase of growth
Antioxidants represent a staple category in the dietary supplement market. But there has always been fierce debate about how much consumers really understand about the term antioxidants. Plenty of people support the term and believe in its health relevance, and yet others think antioxidants has lost a lot of its meaning over time.

NextFerm wins SME phase 1 grant from EU Horizon 2020 program
Horizon 2020, the EU’s largest research and innovation program, has awarded an SME phase 1 grant to NextFerm. This grant will enable NextFerm to continue its development for its groundbreaking AstafermTM a yeast-derived, fermented astaxanthin technology for human nutrition.

NextFerm and Soft Gel Technologies collaborate to launch new astaxanthin ingredient
“…NextFerm (Yokneam, Israel) and Soft Gel Technologies (Commerce, CA) are releasing a new astaxanthin derived from yeast fermentation called Astaferm. The ingredient is specifically designed for softgel applications and will be offered as ready-to-use softgels, with plans to release a special grade for gummies in the future….”

NextFerm announces new patent application for yeast-based astaxanthin
“…NextFerm Technologies (Yokneam, Israel) has filed a patent for its natural astaxanthin derived from yeast fermentation, called Astaferm. The patent covers the Astaferm novel composition providing excellent antioxidative properties…”

NextFerm Technologies applies for new yeast astaxanthin patent
“…Several studies have shown first evidence of Astaferm’s high antioxidative capacity compared to algae-derived astaxanthin…”

NextFerm files patent for astaxanthin-producing yeast strains
“…The patent allows NextFerm to share its recent study findings with its customers, showing the first evidence of its high antioxidative capacity when compared to algae-derived astaxanthin…..They also support the benefits of a new and different natural source of astaxanthin, encouraging brands and consumers to embrace it and enjoy its huge advantages in terms of potency and flavor. As with other natural sources of astaxanthin, it is safe without any known health risks…”

Lallemand strengthens ties with fermentation-ingredients company NextFerm
“…Ingredient supplier NextFerm (Israel), which focuses on producing nutritional and functional ingredients using non-GMO single-cell fermentation, announced it has received an additional support from Lallemand Health Solutions (Montreal), a supplier of yeast, bacteria, and specialty ingredients. Together, the companies are collaborating on the commercialization of yeast strains for industries such as baking and biofuel…”

Fermentation may be the ingredient engine of the future
“…We also have a 10% odorless fluid—something algae technology simply doesn’t carry—thus opening another compelling area of gummies and related applications..”

NextFerm Technologies files patent for astaxanthin-producing yeast strains
The patent will cover the specific yeast strains used to produce astafermTM

Israeli firm turns to yeast to revolutionize the fake meat market
“Very few people are talking about the biological benefits of the protein..” NextFerm founder Boaz Noy says.